Drug resistance in Chromobacterium violaceum

Genetics and Molecular Research

Volumn 3, Issue 1, 2004, Pages 134-147

  Fantinatti Garboggini, Fabiana ^a   De Almeida, Rosana ^b   Portillo, Vinícius Do Amaral ^a   Barbosa, Tércio A P ^a   Trevilato, Peterson Beltramini ^b   Neto, Cícero Eduardo Ramalho ^c   Coêlho, Rosângela Duarte ^d   Silva, Denise Wanderlei ^c   Bartoleti, Luciana Aparecida ^b   Hanna, Ebert Seixas ^b   Brocchi, Marcelo ^b   Manfio, Gilson P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Antibiotics; Chromobacterium violaceum; Resistance

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BICOZAMYCIN; CEPHALOSPORIN; CHLORAMPHENICOL; KASUGAMYCIN; METHYLENOMYCIN; PENICILLIN G; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CHROMOBACTERIUM; CHROMOBACTERIUM VIOLACEUM; CONFERENCE PAPER; GENOME ANALYSIS; MULTIDRUG RESISTANCE; NONHUMAN; OPEN READING FRAME; ARTICLE; BACTERIAL GENOME; DRUG EFFECT; GENETICS;

ANIMALIA; BACTERIA (MICROORGANISMS); CHROMOBACTERIUM; CHROMOBACTERIUM VIOLACEUM;

ANTI-BACTERIAL AGENTS; CHROMOBACTERIUM; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; OPEN READING FRAMES;

EID: 2542432077     PISSN: 16765680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Aldridge, K.E., Valainis, G.T. and Sanders, C.V. (1988). Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn. Microbiol. Infect. Dis. 10: 31-39.
2. Alekshun, M.N., Levy, S.B., Mealy, T.R., Seaton, B.A. and Head, J.F. (2001). The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat. Struct. Biol. 8: 710-714.
3. Berkowitz, F.E. and Metchock, B. (1995). Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children. Pediatr. Infect. Dis. J. 14: 97-100.
4. Brooks, G.F., Butel, J.S. and Morse, S.A. (2001). Medical Microbiology. McGraw-Hill/Appleton & Lange, New York, NY, USA.
5. Brown, M.H., Paulsen, I.T. and Skurray, R.A. (1999). The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31: 394-395.
6. Cain, B.D., Norton, P.J., Eubanks, W., Nick, H.S. and Allen, C.M. (1993). Amplification of the baca gene confers bacitracin resistance to Escherichia coli. J. Bacteriol. 175: 3784-3789.
7. Chong, C.Y. and Lam, M.S. (1997). Case report and review of Chromobacterium sepsis - a gram-negative sepsis mimicking melioidosis. Singapore Med. J. 38: 263-265.
8. del Castillo, I., Gomez, J.M. and Moreno, F. (1990). mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B 17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid. J. Bacteriol. 172: 437-445.
9. Dromigny, J.A., Fall, A.L., Diouf, S. and Perrier-Gros-Claude, J.D. (2002). Chromobacterium violaceum: a case of diarrhea in Senegal. Pediatr. Infect. Dis. J. 21: 573-574.
10. Edgar, R. and Bibi, E. (1999). A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J. 18: 822-832.
11. Kaufman, S.C., Ceraso, D. and Shugarensky, A. (1986). First case report from Argentina of a fatal septicemia caused by Chromobacterium violaceum. J. Clin. Microbiol. 23: 956-958.
12. Liu, C.H., Chu, R.M., Weng, C.N., Lin, Y.L. and Chi, C.S. (1989). An acute pleuropneumonia in a pig caused by Chromobacterium violaceum. J. Comp. Pathol. 100: 459-463.
13. Lomovskaya, O. and Lewis, K. (1992). Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. USA 89: 8938-8942.
14. Lomovskaya, O., Lewis, K. and Matin, A. (1995). EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J. Bacteriol. 177: 2328-2334.
15. Ma, D., Alberti, M., Lynch, C., Nikaido, H. and Hearst, J.E. (1996). The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 19: 101-112.
16. Martinez, R., Velludo, M.A., Santos, V.R. and Dinamarco, P.V. (2000). Chromobacterium violaceum infection in Brazil. A case report. Rev. Inst. Med. Trop. São Paulo 42: 111-113.
17. Midani, S. and Rathore, M. (1998). Chromobacterium violaceum infection. South. Med. J. 91: 464-466.
18. Neal, R.J. and Chater, K.F. (1987). Nucleotide sequence analysis reveals similarities between proteins determining methylenomycin A resistance in Streptomyces and tetracycline resistance in eubacteria. Gene 58: 229-241.
19. Nikaido, H. (1996). Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178: 5853-5859.
20. Nikaido, H. and Zgurskaya, H.I. (2001). AcrAB and related multidrug efflux pumps of Escherichia coli. J. Mol. Microbiol. Biotechnol. 3: 215-218.
21. Oliver, A., Cantón, R., Campo, P., Baquero, F. and Blázquez, J. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251-1253.
22. Pares, S., Mouz, N., Petillot, Y., Hakenbeck, R. and Dideberg, O. (1996). X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme. Nat. Struct. Biol. 3: 218-219.
23. Perera, S., Punchihewa, P.M., Karunanayake, M.C. and de Silva, N. (2003). Fatal septicaemia caused by Chromobacterium violaceum. Ceylon Med J. 48: 26-27.
24. Petrillo, V.F., Severo, V., Santos, M.M. and Edelweiss, E.L. (1984). Recurrent infection with Chromobacterium violaceum: first case report from South America. J. Infect. 9: 167-169.
25. Poole, K. (2001). Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3: 255-264.
26. Rawlings, N.D. and Barrett, A.J. (1994). Families of serine peptidases. Methods. Enzymol. 244: 19-61.
27. Richard, C. (1993). Chromobacterium violaceum, opportunist pathogenic bacteria in tropical and subtropical regions. Bull. Soc. Pathol. Exot. 86: 169-173.
28. Salyers, A.A. and Whitt, D.D. (2001). Bacterial Pathogenesis: A Molecular Approach. 2nd edn. ASM Press, Washington, D.C., USA.
29. Shao, P.L., Hsueh, P.R., Chang, Y.C., Lu, C.Y., Lee, P.Y., Lee, C.Y. and Huang, L.M. (2002). Chromobacterium violaceum infection in children: a case of fatal septicemia with nasopharyngeal abscess and literature review. Pediatr. Infect. Dis. J. 21: 707-709.
30. Strauss, E. (1999). A symphony of bacterial voices. Science 284: 1302-1304.
31. Ti, T.Y., Tan, W.C., Chong, A.P. and Lee, E.H. (1993). Nonfatal and fatal infections caused by Chromobacterium violaceum. Clin. Infect. Dis. 17: 505-507.
32. van Veen, H.W., Venema, K., Bolhuis, H., Oussenko, I., Kok, J., Poolman, B.A.J. and Konings, W.N. (1996). Multidrug resistance mediated by a bacterial homologue of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 93: 10668-10672.
33. Vasconcelos, A.T.R., Almeida, D.F., Almeida, F.C., Almeida, L.G.P., Almeida, R., Alves-Gomes, J.A., Andrade, E.M., Antônio, R.V., Araripe, J., Araújo, M.F.F., Astolfi-Filho, S., Azevedo, V., Baptista, A.J., Bataus, L.A.M., Batista, J.S., Beló, A., van den Berg, C., Blamey, J., Bogo, M., Bonatto, S., Bordignon, J., Brito, C.A., Brocchi, M., Burity, H.A., Camargo, A.A., Cardoso, D.D.P., Carneiro, N.P., Carraro, D.M., Carvalho, C.M.B., Cascardo, J.C.M., Cavada, B.S., Chueire, L.M.O., Creczynski-Pasa, T.B., Duran, N., Fagundes, N., Falcão, C.L., Fantinatti, F., Farias, I.P., Felipe, M.S.S., Ferrari, L.P., Ferro, J.A., Ferro, M.I.T., Franco, G.R., Freitas, N.S.A., Furlan, L.R., Gazzinelli, R.T., Gomes, E.A., Gonçalves, P.R., Grangeiro, T.B., Grattapaglia, D., Grisard, E.C., Guimarães, C.T., Hanna, E.S., Hungria, M., Jardim, S.N., Laurino, J., Leoi, L.C.T., Lima, L.F.A., Loureiro, M.F., Lyra, M.C.C.P., Macedo, M., Madeira, H.M.F., Manfio, G.P., Maranhão, A.Q., Martins, W.S., di Mauro, S.M.Z., Medeiros, S.R.B., Meissner, R.V., Moreira, M.A.M., Nascimento, F.F., Nicolas, M.F., Oliveira, J.G., Oliveira, S.C., Paixão, R.F.C., Parente, J.A., Pedrosa, F.O., Pena, S.D.J., Pereira, J.O., Pereira, M., Pinto, L.S.R.C., Pinto, L.S., Porto, J.I.R., Potrich, D.P., Ramalho-Neto, C.E., Reis, A.M.M., Rigo, L.U., Rondinelli, E., Santos, E.B.P., Santos, F.R., Schneider, M.P.C., Seuanez, H.N., Silva, A.M.R., Silva, A.L.C., Silva, D.W., Silva, R., Simões, I.D.C., Simon, D., Soares, C.M.A., Soares, R.B.A., Souza, E.M., Souza, K.R.L., Souza, R.C., Steffens, M.B.R., Steindel, M., Teixeira, S.R., Urmenyi, T., Vettore, A., Wassem, R., Zaha, A. and Simpson, A.J.G. (2003). Complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc. Natl. Acad. Sci. USA 100: 11660-11665.
34. Vila-Sanjurjo, A., Squires, C.L. and Dahlberg, A.E. (1999). Isolation of kasugamycin resistant mutants in the 16 S ribosomal RNA of Escherichia coli. J. Mol. Biol. 293: 1-8.
35. Yanofsky, C. and Horn, V. (1995). Bicyclomycin sensitivity and resistance affect Rho factor-mediated transcription termination in the tna operon of Escherichia coli. J. Bacteriol. 177: 4451-4456.